NCT05496231 2025-02-03
A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age
GlaxoSmithKline
Phase 1/2 Completed
GlaxoSmithKline
Avita Medical
AlloVir
GlaxoSmithKline
Merck Sharp & Dohme LLC